From the Department of Cardiology, King Edward Memorial Hospital, Mumb no relationships relevant to the contents of this paper to disclose. Manuscript received December 2, 2015; accepted December 19, 2015. steal. We report our experience of successful transcatheter closure of the coronary arterial fistula arising from the left main CA and draining into the superior vena cava–right atrium (SVC-R...

We report a patient with a significant residual left-to-right shunt who underwent surgical repair for traumatic VSD. This 13-year-old boy was stabbed with a pair of scissors through his heart. After initial life-saving surgery with lacerated left ventricular wall repair and VSD closure, residual VSD was noted. Six months later, we performed a successful transcatheter closure of the residual VSD...

T he paper by Koskinas et al. (1) in this issue of JACC: Cardiovascular Interventions describes a large series of left atrial appendage closures (LAAC) and very early outcomes data. The authors’ experience is admirable, dates back to the very beginning of endovascular LAAC, and incorporates a now obsolete device (Percutaneous Left Atrial Appendage Transcatheter Occlusion [PLAATO]) and a largely...

INTRODUCTION AND OBJECTIVES Percutaneous closure of paravalvular leakage is an alternative to surgery in high-risk patients, but its use has been limited by a lack of specific devices. More appropriate devices-like the Amplatzer Vascular Plug III-have recently been developed, but information about their efficacy and safety is still scarce. The objective of the present study was to assess the mi...

PURPOSE For the successful completion of transcatheter closure of atrial septal defects with the Amplatzer septal occluder, shape of the defects should be considered prior to selecting the device. The purpose of this study is to evaluate the results of a transcatheter closure of oval shaped atrial septal defect. MATERIALS AND METHODS From November 2009 until November 2011, cardiac computed to...

OBJECTIVE To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal defects and fenestrated Fontan with the Amplatzer septal occluder. METHODS Fifteen consecutive patients, with a significant interatrial communications, were considered for the procedure; four patients with defects that were too large or with deficient margins were excluded after initial transesoph...

BACKGROUND In an effort to reduce x-ray exposure, we developed a technique for transcatheter closure of atrial septal defects under echocardiographic guidance without fluoroscopy. To assess the efficiency of this procedure for routine use, we compared our initial results with those for the conventional procedure. METHODS AND RESULTS Twenty-two randomly selected patients (median age 18 years; ...

BACKGROUND Device closure of Secundum atrial septal defect (ASD) is an accepted mode of treatment in selected patients with a suitable defect. The major initial concern over the long-term outcome has been erosions and more recently development of aortic regurgitation. Objective was to assess the intermediate and long term outcome of patients with device closure of ASD with special reference to ...

Patent ductus arteriosus (PDA) constitutes 6 to 11% of all congenital heart defects. While surgical ligation and video-assisted, thoracoscopic interruption of PDA are still available, transcatheter occlusion of PDAs has recently assumed a major role in closure of PDA. A large number of devices have been designed and tested both in animal models and human subjects, but only few devices (free and...

The purpose of this study was to present our initial experience with the Amplatzer® Vascular Plug (AVP) 4 in various arterial environments. This material was designed for the embolization of peripheral small vessels using a diagnostic catheter. Herein, the following three procedures using the AVP 4 were described: hemodialysis fistula occlusion as a treatment for the steal pheno...